Table 2.
Characteristics of the study subjects.
| Parameter/Disease | Controls n = 20 |
HCV n = 21 |
PBC n = 10 |
PSC n = 6 |
ALD n = 20 |
AIH n = 20 |
|---|---|---|---|---|---|---|
| Sex (male/female) | 11/9 | 10/11 | 1/9 | 4/2 | 16/4 | 8/12 |
| Age (years) | 63 ± 10 | 52 ± 5 | 59 ± 4 | 43 ± 10 | 51 ± 6 | 47 ± 16 |
| Child–Pugh (A/B/C) | - | 7/10/4 | 2/4/4 | 3/3/0 | 0/8/12 | 6/6/8 |
| Total bilirubin (mg/dl) | 0.59 ± 0.25 | 2.38 ± 1.37 | 6.42 ± 6.72 | 8.14 ± 8.14 | 4.4 ± 4.02 | 3.54 ± 3.53 |
| Albumin (g/dl) | 3.89 ± 0.38 | 3.31 ± 0.45 | 3.13 ± 0.65 | 3.7 ± 0.44 | 3.03 ± 0.50 | 3.29 ± 0.39 |
| PT (s) | 12.7 ± 2.3 | 14.4 ± 2.0 | 12.5 ± 1.2 | 13.2 ± 2.8 | 16.0 ± 2.2 | 14.6 ± 2.5 |
| INR | 1.14 ± 0.21 | 1.39 ± 0.27 | 1.19 ± 0.21 | 1.4 ± 0.52 | 1.47 ± 0.23 | 1.42 ± 0.41 |
HCV: hepatitis C, PBC: primary biliary cholangitis, PSC: primary sclerosing cholangitis, ALD: alcoholic liver disease, AIH: autoimmune hepatitis, PT: prothrombin time, and INR: international normalized ratio. Mean values and standard deviation values are given for quantitative variables.